{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03460223",
      "OrgStudyIdInfo": {
        "OrgStudyId": "NJLT006"
      },
      "Organization": {
        "OrgFullName": "Nanjing Medical University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis",
      "OfficialTitle": "Phase 1 Clinical Trial Using Mesenchymal Stem Cell as Individualized Medicine to Evaluate the Safety and Efficacy in Kidney Fibrosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2018",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 1, 2018",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 1, 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 1, 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "February 23, 2018",
      "StudyFirstSubmitQCDate": "March 4, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 9, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 4, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 9, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Ling Lu",
        "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
        "ResponsiblePartyInvestigatorAffiliation": "Nanjing Medical University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Nanjing Medical University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "In progressive kidney diseases, fibrosis represents the common pathway to end-stage kidney failure. The potential for stem cells to treat kidney failure was recently confirmed. Particularly, mesenchymal stem cell (MSC) has been demonstrated to protect kidney function and alleviating renal injury in these patients. Therefore, the investigators propose a hypothesis that MSCs (MSC) can also improve the disease conditions of kidney fibrosis patients, particularly reducing the decompensated conditions in these patients.",
      "DetailedDescription": "Kidney fibrosis represents the common pathway to end-stage kidney failure.The potential for stem cells to treat kidney failure was recently confirmed. In particular, mesenchymal stem cell (MSC) transplantation has been applicated in the clinic for treat several human diseases such as GVHD, kidyney injury and displayed good tolerance and efficiency. The purpose of this study is to learn whether and how MSCs (MSC) can improve the disease conditions in patients with kidney fibrosis. This study will also look at safety in these patients."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Renal Cirrhosis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "30",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Conventional plus MSC treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: MSC"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "MSC",
            "InterventionDescription": "conventional plus MSC or placebo treatment",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conventional plus MSC treatment"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "BUN",
            "PrimaryOutcomeDescription": "The evaluation of serum levels of BUN",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Cr",
            "PrimaryOutcomeDescription": "The evaluation of serum levels of Cr",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "eGFR",
            "PrimaryOutcomeDescription": "The evaluation of serum levels of eGFR",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Cystatin C",
            "PrimaryOutcomeDescription": "The evaluation of serum levels of Cystatin C",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Urine protein",
            "PrimaryOutcomeDescription": "The evaluation of serum levels of Urine protein",
            "PrimaryOutcomeTimeFrame": "24 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Hb",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of Hb",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Hct",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of Hct",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Ca",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of Ca",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "P",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of P",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "ALT",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of ALT",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "PTH",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of PTH",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "VitD",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of VitD",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "ALB",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of ALB",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "TC",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of TC",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "TG",
            "SecondaryOutcomeDescription": "The evaluation of serum levels of TG",
            "SecondaryOutcomeTimeFrame": "24 months"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "Evaluation of renal fibrosis",
            "OtherOutcomeDescription": "The pathology decrease in grade of renal fibrosis",
            "OtherOutcomeTimeFrame": "24 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nWritten informed consent.\nGlomerular sclerosis ratio ≤ 50%.\nRenal tubulointerstitial fibrosis ratio ≤ 50%.\nNegative pregnancy test.\nModerately active disease under standard treatment.\n\nExclusion Criteria:\n\n1. Severe infection and cardiovascular disease, shock, secondary liver disease and malignant tumor.",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Ling Lu, M.D, PH.D",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-025-68136053",
            "CentralContactEMail": "lvling@njmu.edu.cn"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Jinhai Tang, M.D, PH.D",
            "OverallOfficialAffiliation": "Nanjing Medical University",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000005355",
            "ConditionMeshTerm": "Fibrosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M7637",
            "ConditionBrowseLeafName": "Fibrosis",
            "ConditionBrowseLeafAsFound": "Fibrosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10255",
            "ConditionBrowseLeafName": "Liver Cirrhosis",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          }
        ]
      }
    }
  }
}